Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
WFM | as of 07/12/12 new code is adj | 15/12/12 | 2 | 1.8K | |||
|
|||||||
WFM | Ann: Change of Name to Adslot Ltd | 04/12/12 | 0 | 928 | |||
|
|||||||
WFM | Ann: Change of Director's Interest Notice - B | 28/11/12 | 0 | 721 | |||
|
|||||||
WFM | Ann: Change of Director's Interest Notice - G | 28/11/12 | 0 | 709 | |||
|
|||||||
WFM | Ann: Appendix 3B | 27/11/12 | 0 | 786 | |||
|
|||||||
WFM | Ann: Results of 2012 Annual General Meeting | 27/11/12 | 0 | 791 | |||
|
|||||||
WFM | Ann: Chief Executive's Address to Shareholder | 27/11/12 | 0 | 508 | |||
|
|||||||
WFM | Ann: Chairman's Address to Shareholders | 27/11/12 | 0 | 635 | |||
|
See All Discussions